R 311913Z AUG 21 MID200001090997U
FM CNO WASHINGTON DC
INFO SECNAV WASHINGTON DC
MSGID/NAVADMIN/CNO WASHINGTON DC/CNO/AUG//
SUBJ/2021-2022 NAVY MANDATORY COVID-19 VACCINATION AND REPORTING POLICY//
NARR/REF A IS THE SECRETARY OF DEFENSE MEMO MANDATING CORONAVIRUS DISEASE
2019 VACCINATION FOR DEPARTMENT OF DEFENSE SERVICE MEMBERS.
REF B IS ALNAV 062/21, 2021-2022 DEPARTMENT OF NAVY MANDATORY COVID-19
REF C IS BUMEDINST 6230.15B, IMMUNIZATIONS AND CHEMOPROPHYLAXIS FOR THE
PREVENTION OF INFECTIOUS DISEASE.
REF D IS BUPERSINST 1730.11A, STANDARDS AND PROCEDURES GOVERNING THE
ACCOMMODATION OF RELIGIOUS PRACTICES.
REF E IS MILPERSMAN 1730-020, IMMUNIZATION EXEMPTIONS FOR RELIGIOUS BELIEFS.
REF F IS NAVADMIN 088/21, SARS-COV-2 VACCINATION AND REPORTING POLICY UPDATE.
REF G IS DEFENSE HEALTH AGENCY INTERIM PROCEDURES MEMORANDUM 20-004,
DEPARTMENT OF DEFENSE (DOD) CORONAVIRUS DISEASE 2019 (COVID-19) VACCINATION
PROGRAM IMPLEMENTATION PROGRAM.
REF H IS ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS MEMO, CO-
ADMINISTRATION OF CORONAVIRUS DISEASE 2019 VACCINES WITH OTHER VACCINES.
POC/BUMED COVID-19 CRISIS ACTION TEAM / (703) 681-1125/EMAIL:
OPNAV COVID-19 CRISIS ACTION TEAM / (703) 571-2822 /
RMKS/1. Background. Disease modeling forecasts that severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-
19, will continue to spread throughout the remainder of 2021. Data and
modeling also indicate that the available vaccines will continue to be
effective against severe illness and mortality caused by COVID 19. Of note,
all Navy COVID deaths have been individuals not immunized (one individual was
partially vaccinated). In consideration of this persistent health and
readiness threat to Navy service members, vaccination against COVID-19 is now
mandatory per references (a) and (b). This NAVADMIN provides guidance
regarding implementation within the Navy.
2. Policy. In accordance with references (a), (b), and this NAVADMIN, Navy
service members will be fully vaccinated against COVID-19 through
administration of vaccines that have received Food and Drug Administration
(FDA) licensure or through the voluntary administration of vaccines under FDA
Emergency Use Authorization (EUA) or World Health Organization (WHO)
Emergency Use Listing.
2.a. Navy Service Members. Active duty service members, service members in
the selected reserve, and service members in the Individual Ready Reserve are
considered Navy service members for the purposes of this NAVADMIN.
2.b. Fully Vaccinated. Navy service members vaccinated per paragraph 2 or
voluntarily immunized with a COVID-19 vaccine under FDA EUA or WHO Emergency
Use Listing in accordance with applicable dose requirements prior to, or
after, the establishment of this policy are considered fully vaccinated.
Navy service members are considered fully vaccinated two weeks after
completing the second dose of a two-dose COVID-19 vaccine or two weeks after
receiving a single dose of a one-dose COVID-19 vaccine. Booster shots are
still under evaluation and will be addressed via separate message.
2.c. Coordination. Military Treatment Facilities (MTFs) will coordinate
ordering, distributing, and administering vaccines, along with their
supported activities, units, and other eligible populations.
2.d. COVID-19 Disease Prevention. Vaccination has proven to be the most
effective defense against serious illness caused by COVID-19. Maintaining a
clean work environment, good hygiene practices including cough/sneeze
etiquette, and managing workforce exposure (e.g., social distancing,
teleworking, and sick leave) also continue to be effective tools in reducing
the spread of COVID-19.
3. COVID-19 Vaccination Administering Requirements and Reporting
3.a. COVID-19 vaccination is mandatory for all DoD service members who are
not medically or administratively exempt per references (c), (d), and (e).
Navy service members who are not medically or administratively exempt shall
be fully vaccinated against
COVID-19 as defined in paragraph 2.b above.
3.b. Active duty Navy service members will be fully vaccinated within 90
days from the date of reference (b). Ready Reserve Navy service members will
be fully vaccinated within 120 days from the date of reference (b). New
accessions will be fully vaccinated as soon as practicable following service
3.c. This NAVADMIN constitutes a lawful order. Refusal to be fully
vaccinated against COVID-19, absent an approved exemption, will constitute a
failure to obey a lawful order and is punishable under the Uniform Code of
Military Justice and/or may result in administrative action. Adjudication
will be in accordance with paragraph 3.e.(5) below. Prior to receiving the
COVID-19 vaccine, Navy service members will have access to healthcare
providers to address questions regarding the risks of COVID-19 and the
benefits of COVID-19 vaccination.
3.d. Exemptions. The two types of exemptions from immunization are medical
and administrative. Administrative exemptions include religious
accommodations, per references (d) and (e), as well as others per reference
(c). The process for obtaining exemptions for mandatory vaccinations is
provided in reference
(c) for medical and administrative exemptions and references
(d) and (e) for religious accommodations. Specifically for the COVID-19
vaccination, in addition to the processes in reference (c), the authority to
grant approval of a permanent medical exemption is the first Navy Medical
Department Flag Officer in the medical providers chain of command. Medical
Departments may send questions regarding the permanent medical exemption
process to usn.ncr.bumedfchva.mbx.bumed--- 2019-ncov-response-
3.d.(1). A history of COVID-19 disease and/or positive serology does not
exempt a Navy service member from receiving a COVID-19 vaccine. Those Navy
service members who previously received a medical exemption from COVID-19
vaccine while the vaccines were authorized under an EUA will be reevaluated
per paragraph 3.d above.
3.d.(2). Navy service members who are actively participating in COVID-19
clinical trials are exempt from mandatory vaccination against COVID-19 until
the trial is complete.
3.e. Commanders, Commanding Officers, and Officers in Charge will:
3.e.(1). Identify Navy service members who are not vaccinated against COVID-
19 using Medical Readiness Reporting System
(MRRS) detailed in paragraph 3.f below.
3.e.(2). Provide sufficient resources to local MTFs or vaccination locations
to execute local vaccination plans.
In coordination with local commanders, MTFs will develop plans to administer
3.e.(3). In coordination with supporting cognizant medical authority, direct
that unvaccinated Navy service members will initiate vaccination with an FDA-
licensed vaccine or, optionally and alternatively, with a vaccine approved
for emergency use, on a timeline that achieves full vaccination per paragraph
3.b above. This direction will include information and guidance regarding
vaccine availability and administering locations.
3.e.(4). For Navy service members without a pending exemption request or
whose exemption request was denied, provide counseling regarding refusal to
take the COVID-19 vaccine. This counseling will include access to a
healthcare professional to answer questions regarding the risks of COVID-19
and the benefits of
COVID-19 vaccinations. Commands will then issue a uniform NAVPERS 1070/613
(Page 13) ordering initiation of the COVID-19 vaccine series, to be completed
within the time requirements of paragraph 3.b above. An example NAVPERS
1070/613 can be found at:
3.e.(5). For Navy service members who remain unvaccinated, and who have or
are expected to exceed the time requirements of paragraph 3.b, their ultimate
disposition will be determined by the designated COVID Consolidated
Disposition Authority (CCDA). The CCDA will serve as the central authority
for adjudication and will have at his or her disposal the full range of
administrative and disciplinary actions. Until further notice, authority is
withheld for initiating non- judicial punishment, courts-martial, or
administrative separation in cases of Navy Service Members refusing the
vaccine. The assigned CCDA and specific required reporting procedures and
information will be promulgated via separate message.
3.f. COVID-19 Vaccination Reporting
3.f.(1). Navy service member vaccination administration compliance will be
monitored via MRRS. Designated command personnel will access MRRS to track
personnel to ensure compliance.
3.f.(2). Vaccine administrators must report vaccine administration errors,
serious adverse vaccine reactions or clinically significant adverse events in
the Vaccine Adverse Event Reporting System:
3.f.(3). Vaccine administrators must ensure that documentation of COVID-19
vaccine administration is coded to accurately reflect the type of vaccine
3.f.(4). COVID-19 immunization documentation will be completed within an
approved electronic health record (EHR). Afloat units will enter COVID-19
immunizations into the Shipboard Automated Medical System/Theater Medical
Information Program for subsequent transfer to MRRS. Garrison units will
enter COVID-19 immunizations into AHLTA/MHS GENESIS for subsequent transfer
When an approved EHR is not available, readiness documentation may be entered
directly in MRRS, but must also be entered into EHR once available.
3.f.(5). Navy service members who receive the vaccine from a retail network
pharmacy or other non-DoD vaccine administrator must provide documentation of
COVID-19 vaccination to their respective command no later than the next duty
day for Active Component or within 7 days for Reserve Component for entry
into EHR and/or MRRS.
3.f.(6). Shore-based commands will request access to MRRS based on unit
identification code by submitting a system access authorization request
available at: //mrrs.dc3n.
navy.mil/mrrs (note: MRRS Web address is case sensitive).
Point of contact: MRRS program office, firstname.lastname@example.org /
(800) 537-4617 / (504) 697-7070 / DSN: 647-7070. Ship-based commands may
utilize Navy Medicine Online or Shipboard Non-Tactical Automated Data
Processing Automated Medical System to populate MRRS.
4. COVID-19 Vaccination Administration
4.a. Vaccine administrators should follow the guidance provided in
references (f) and (g).
4.b. Per reference (h), there is no harm (contraindication) for co-
administration of the COVID-19 vaccination with other vaccines.
4.c. COVID-19 Vaccine Ordering. Naval Medical Logistics Command is
responsible for coordinating distribution of
COVID-19 vaccine for all Navy and Marine Corps activities:
COVID-19 vaccine is centrally funded. Navy activities will place their order
for COVID-19 vaccine via USAMMA-DOC's secure web site:
4.d. COVID-19 Vaccine Integrity. If temperature limits are exceeded during
shipment, upon receipt immunization sites must call DLA or USAMMA-DOC at 301-
DSN: 343-4318/8002 and DLA email@example.com or
paacoldchainteam(AT)@dla.mil. For temperature limits exceeded in storage
please refer to the following website:
4.e. Vaccination and Reporting Timeline
4.e.(1). Due to the risk of rapid infection transmission within units and
potential impact on operations, vaccines should be given as quickly as
possible. MTFs should be prepared to begin administration of vaccine within
24 hours of receipt. If directly receiving the vaccine, active duty
operational units have 72 hours (three working days) following receipt of the
vaccine to begin documentation, administration, and vaccination reporting.
4.e.(2). As schedules vary for Navy service members in the Selected Reserve
or Individual Ready Reserve, NMLC will coordinate with DLA and the ordering
Reserve Command for the vaccine to arrive the week of a drill weekend.
Units have 30 days following receipt of the vaccine to document, administer,
and report vaccination.
4.e.(3). Installations and MTFs may use the Navy Family Accountability and
Assessment System, similar to seasonal influenza efforts, conduct a Pandemic
COVID-19 response exercises in conjunction with the COVID-19 vaccine program.
5. Points of contact:
5.a. OPNAV: CAPT Steven Tarr III, (703) 614-9250 /
5.b. BUMED: BUMED COVID-19 CRISIS ACTION TEAM /
(703) 681-1125 / Email: USN.NCR.BUMEDFCHVA.MBX.BUMED--- 2019-NCOV-RESPONSE-
6. Released by VADM W. R. Merz, Deputy Chief of Naval Operations for
Operations, Plans and Strategy, OPNAV N3/N5.//